Fundraising Fox
Humabiologics
Phoenix, US · Founded 2018 · Arizona corporation
Find your way into Humabiologics
Sign up to see every warm intro you have to Humabiologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Humabiologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Humabiologics is a regenerative medicine company that produces human-derived biomaterials from donated human tissues for use in regenerative medicine research and drug discovery. It supplies these biomaterials to scientists and researchers, manufacturing under FDA, ISO, and cGMP standards.
Founders & leadership
Humabiologics was founded in 2018 by Mohammad Albanna.
MA
Mohammad AlbannaCEO & FounderMohammad Albanna is a tissue engineering and regenerative medicine executive with 15+ years of experience in translational research and product development across engineered skin, cartilage, bone, and cardiovascular tissues. He previously held senior leadership roles developing tissue-engineered products, has authored publications in scientific journals, edited a textbook on skin tissue engineering, and holds multiple patents in the field.
Funding
SEC filings, press & company announcements$692.4K disclosed across 2 of 3 rounds · 2020–2024
- Undisclosed amountSeed RoundFeb 2024Source ↗
▶$667.4KraisedJan 2022 · 7 investors · BiotechnologyRule 506(b)
▶$667.4KraisedJan 2022 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mohammad AlbannaExecutive Officer, Director
- Dan MahaffeyExecutive Officer
- Offering amount
- $3M
- Amount sold
- $667.4K
- Minimum investment
- $25K
- First sale
- Dec 2021
- Incorporated
- Corporation, Arizona, 2018
- Federal exemptions
- 06b
▶$25KraisedJan 2020 · 1 investors · BiotechnologyRule 506(b)
▶$25KraisedJan 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mohammad AlbannaExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $25K
- Minimum investment
- $5K
- First sale
- Jan 2020
- Incorporated
- Corporation, Arizona, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Humabiologics do?
- Humabiologics is a regenerative medicine company that produces human-derived biomaterials from donated human tissues for use in regenerative medicine research and drug discovery. It supplies these biomaterials to scientists and researchers, manufacturing under FDA, ISO, and cGMP standards.
- Who founded Humabiologics?
- Humabiologics was founded by Mohammad Albanna in 2018.
- How much funding has Humabiologics raised?
- Humabiologics has disclosed $692.4K raised across 2 of its 3 known rounds.
- Where is Humabiologics headquartered?
- Humabiologics is headquartered in Phoenix, US.